Table 4 (cont'd)
Patient
No. & sex
Age at
surgery
Years post
exposure
Pathologic
diagnosis
Remarks
Utirik exposed
2229 F
32
15 1/2
Follicular carcinoma
2208 F
2212 F
53
53
19
19
Adenomatous nodules
Adenomatous nodules
with Hurthle cell
2221 F
73
19
Adenomatous nodules
with follicular
Hyperplasia, focal
atypia
2160 F
2150 M
2194 F
2261x M
2236 M
2193 F
2195 F
25
34
59
50
35
56
49
21
22
22
23
24
25
25
Papillary carcinoma
Follicular adenoma
Papillary carcinoma
No diagnostic lesion
Follicular adenoma
Adenomatous nodules
Adenomatous nodule
Hyperplasia
2215 F
2147
2196
2239
2132
F
F
F
F
adenoma
1/2
1/2
1/2
1/2
58
° 25 1/2
30
63
29
28
-25 1/2
26 1/2
27
27
adenoma
Divided opinion:
atypical adenoma
Hyperplasia
Lymph node metastases
Focal hyperplasia
Papillary hyperplasia
Adenomatous nodules
with occult papillary
carcinoma
Adenomatous nodules
Diffuse
Adenomatous nodules
Adenomatous nodules
Adenomatous nodule
Fibrosis
Rongelap unexposed controls
938 F
829 F
841 F
1007
1573
867
4023
1556
M
M
F
F
F
a
Suc|
33
41
41
66
28
50
44
34
Adenomatous nodule
Adenomatous nodule
Papillary hyperplasia
Adenomatous nodules
with occult papillary
carcinoma
Papillary carcinoma
Fibrosis, hyperplasia
Papillary carcinoma
Adenomatous nodule
Fibrosis
Adenomatous nodule
Papillary hyperplasia
No diagnostic lesion
- 65 -